Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Feasibility Study of MRI Guided Stereotactic Ablative Radiotherapy

NCT05903430 is registered in ClinicalTrials.gov with The Christie NHS Foundation Trust as lead sponsor.

NCT NCT05903430
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05903430 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Feasibility Study of MRI Guided Stereotactic Ablative Radiotherapy
Lead sponsor
The Christie NHS Foundation Trust
Phase
Observational
Overall status
Recruiting
Start date
August 29, 2025
Completion date
January 29, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abdominal cancer, lung cancer